# SODIUM SULFITE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid2044260
Categories: beauty, cleaning, industrial, pharma
Functions: Antioxidant, Filler, Flux agent, Fragrance, Hair waving or straightening, Preservative, Processing aids not otherwise specified, Reducing agent, Stabilizing agent, pH regulating agent, pulp and paper, water treatment
Identifier: DTXSID2044260

> SODIUM SULFITE is used as antioxidant / filler. EPA CPDat observed this chemical in 3033 composition records across product categories including Laboratory supplies, Specialty occupational products, Medical/dental. Assessed from 23 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 3033 composition records across product categories including Laboratory supplies, Specialty occupational products, Medical/dental.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 3033 composition records across product categories including Laboratory supplies, Specialty occupational products, Medical/dental. EPA CPDat classifies this chemical for functional uses including Preservative, Hair waving or straightening, Antioxidant.
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 0.02 %w/v
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 96 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 96 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 4 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 0.2 %w/v
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Potency: 0.5 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CONCENTRATE; Potency: 0.3 mg/1ml
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Potency: 1.15 mg/1ml
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Potency: 5 mg
- US: inactive ingredient database — Route: SOFT TISSUE; Dosage form: INJECTION; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 0.15 %w/v
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 8 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SHAMPOO; Potency: 0.05 %w/w
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._